Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood

• Status: Completed
• Trial end date: 1969-12-31

Summary

The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + rosuvastatin calcium combination therapy with ABT-335 and rosuvastatin calcium monotherapy in subjects with multiple abnormal lipid levels in the blood.

• Phase: Phase 3

Details

• Lead Sponsor: Abbott
• Treatments: Calcium; Calcium, Dietary; Fenofibric acid; Rosuvastatin Calcium